Dr. Jeffrey Goldberg will talk about advances from the laboratory shedding new light on the pathophysiology of glaucoma and generating novel approaches to neuroprotection and vision restoration. He will then cover advances in the clinical trials being done with glaucoma patients, at Stanford and elsewhere, that are beginning to show positive signals of vision protection and enhancement in patients.